About Signaling lymphocytic activation molecule
Signaling lymphocytic activation molecule (SLAMF1) is a protein
from Homo sapiens identified by UniProt accession
Q13291, 335 residues long.
MolForge cross-references it against 0 known binders and
194 disease associations.
Target properties
| Protein name | Signaling lymphocytic activation molecule |
| UniProt accession | Q13291 |
| Gene | SLAMF1 |
| Organism | Homo sapiens |
| Length | 335 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (194)
Diseases linked to this target (Open Targets).
- eosinophil count · score 0.40
- eosinophil percentage of leukocytes · score 0.32
- cognitive decline measurement · score 0.28
- memory performance · score 0.28
- PHF-tau measurement · score 0.23
- blood protein measurement · score 0.20
- mosquito bite reaction itch intensity measurement · score 0.14
- inflammatory bowel disease · score 0.14
- chronic lymphocytic leukemia · score 0.09
- infection · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13291-F1 | alphafold | PREDICTED | 74.92 | — |
Amino-acid sequence (335 residues)
MDPKGLLSLT FVLFLSLAFG ASYGTGGRMM NCPKILRQLG SKVLLPLTYE RINKSMNKSI HIVVTMAKSL ENSVENKIVS LDPSEAGPPR YLGDRYKFYL ENLTLGIRES RKEDEGWYLM TLEKNVSVQR FCLQLRLYEQ VSTPEIKVLN KTQENGTCTL ILGCTVEKGD HVAYSWSEKA GTHPLNPANS SHLLSLTLGP QHADNIYICT VSNPISNNSQ TFSPWPGCRT DPSETKPWAV YAGLLGGVIM ILIMVVILQL RRRGKTNHYQ TTVEKKSLTI YAQVQKPGPL QKKLDSFPAQ DPCTTIYVAA TEPVPESVQE TNSITVYASV TLPES
Explore Signaling lymphocytic activation molecule with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets